NCT07537062 The EFFECT of VİRTUAL REALİTY HEADSETS on ANXİETY, FEAR and PHYSİOLOGICAL PARAMETERS in CHİLDREN With CANCER UNDERGOİNG INTRATHECAL CHEMOTHERAPY
| NCT ID | NCT07537062 |
| Status | Recruiting |
| Phase | — |
| Sponsor | TC Erciyes University |
| Condition | Pediatric Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-01-05 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-01-05 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was planned to determine the effect of virtual reality glasses on anxiety, fear, and physiological parameters in cancer patients aged 4-10 years undergoing intrathecal chemotherapy. The main questions that the study aimed to answer are as follows: * Could virtual reality glasses affect the fear experienced by children undergoing intrathecal chemotherapy? * Could virtual reality glasses affect the anxiety experienced by children undergoing intrathecal chemotherapy? * Does virtual reality goggles have an effect on the physiological parameters of children undergoing intrathecal chemotherapy? Researchers will compare the effects of virtual reality glasses on fear, anxiety, and physiological parameters (heart rate, blood pressure, respiratory rate, and oxygen saturation) in children with cancer undergoing intrathecal chemotherapy to a control group that will not receive any intervention. Cancer patients participating in the study will be given virtual reality glasses before intrathecal chemotherapy treatment.
Eligibility Criteria
Inclusion Criteria: 1. outside the 4-10 age range, 2. have a chronic or genetic illness, 3. have an intellectual, visual, or hearing impairment, 4. cannot adapt to virtual reality glasses, 5. are uncooperative (both themselves and their parents), 6. neither they nor their parents are willing to participate in the research and have not given their verbal or written consent will not be included in the study. Exclusion Criteria: 1. outside the 4-10 age range, 2. have a chronic or genetic illness, 3. have an intellectual, visual, or hearing impairment, 4. cannot adapt to virtual reality glasses, 5. are uncooperative (both themselves and their parents), 6. neither they nor their parents are willing to participate in the research and have not given their verbal or written consent will not be included in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07537062 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 10 Years, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07537062 currently recruiting?
Yes, NCT07537062 is actively recruiting participants. Contact the research team at eda_kalayci937@hotmail.com for enrollment information.
Where is the NCT07537062 trial being conducted?
This trial is being conducted at Kayseri, Turkey (Türkiye).
Who is sponsoring the NCT07537062 clinical trial?
NCT07537062 is sponsored by TC Erciyes University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.